Give Hope Blog
A new standard of care: HIV not a barrier to stem cell transplants
May 2, 2019 | Abe Rosenberg
Where in the early days of the HIV epidemic the idea of stem cell transplants for HIV patients with cancer was considered crazy, the procedure is now commonly performed.
Researcher awarded grant to study promising new HIV therapy
October 18, 2018 | Samantha Bonar
The California Institute for Regenerative Medicine has awarded City of Hope’s Xiuli Wang, Ph.D., $3.8 million to develop chimeric antigen receptor (CAR) T cells that can target and kill HIV-infected cells.
A Functional Cure for HIV/AIDS Might Now Be In Sight
December 1, 2017 | Samantha Bonar
There has been great progress made in the fight against HIV/AIDS, and continued efforts to end this global epidemic. Advances, such as anti-retroviral therapy, have revolutionized HIV treatment. Now, researchers are edging closer to the ultimate goal: a cure.
HIV Stem Cell Trial Patient Strives, Cycles for a Cure
June 13, 2017 | Samantha Bonar
Dan Rojas, 31, who has been living with HIV since 2011, is one of a handful of brave patients participating in a groundbreaking study at City of Hope that seeks a cure for AIDS.
City of Hope Physicians and Scientists Present Trailblazing Research at Annual ASCO Meeting
June 2, 2017 | Letisia Marquez
City of Hope physicians and researchers are headed to Chicago to present groundbreaking research on blood stem cell transplants for HIV patients, immunotherapies, unique treatment options for older adults battling breast cancer and other topics during the American Society of Clinical Oncology’s (ASCO) 2017 Annual Meeting June 2 to 6.
Scripps, City of Hope Team Up to Find New Treatment for HIV
April 25, 2017 | Michael Easterling
A team from The Scripps Research Institute (TSRI) in La Jolla, California, is working with City of Hope’s Center for Gene Therapy to test a cell culture resistant to the HIV virus for efficacy and safety. If testing goes as planned, TSRI and City of Hope investigators may have identified a new treatment for HIV.